Lamotrigine Farmax

Lamotrigine, the active ingredient in Lamotrigine Farmax, is an anticonvulsant presented as an oral tablet for oral use. It treats partial seizures, generalized tonic‑clonic seizures, and bipolar disorder in adults and children as prescribed.

GNH USA supplies Lamotrigine Farmax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamotrigine is an antiepileptic drug used to manage seizure disorders and mood stabilization.

Partial seizures: reduces the frequency and severity of focal seizures. Generalized tonic‑clonic seizures: helps control convulsive seizure activity. Bipolar disorder: stabilizes mood and prevents manic or depressive episodes.

Lamotrigine may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dizziness - Headache - Nausea or vomiting - Skin rash - Blurred vision - Insomnia

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Severe skin reactions (e.g., bullous rash) - Blood dyscrasias such as agranulocytosis - Hepatic failure - Suicidal thoughts or behavior - Severe hypersensitivity reactions

Before using Lamotrigine Farmax, consider the following precautions.

Dose titration: start with a low dose and increase gradually to lower rash risk. Renal impairment: adjust dosage based on renal function. Hepatic impairment: monitor liver function and adjust if needed. Concomitant valproate: may increase lamotrigine levels, requiring dose reduction. Pregnancy: risk unknown; discuss benefits and risks with a healthcare provider. Store at ambient temperature: keep in the original container, protect from moisture and light.

Lamotrigine Farmax can interact with several medicines; monitor accordingly.

Major Interactions (Avoid): - Valproic acid: increases lamotrigine plasma concentrations, raising toxicity risk. - Carbamazepine: decreases lamotrigine levels, potentially reducing efficacy.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may lower lamotrigine levels, requiring seizure monitoring. - Phenobarbital: reduces lamotrigine concentrations, possibly diminishing seizure control. - Rifampin: induces metabolism, leading to decreased lamotrigine exposure.